| Kyler Meredith Evans, CCC-SLP | |
|
35 Brendan Way, Greenville, SC 29615-3514 | |
| (864) 775-6685 | |
| (864) 551-4440 |
| Full Name | Kyler Meredith Evans |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 35 Brendan Way, Greenville, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013679026 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Kyler Meredith Evans, CCC-SLP 35 Brendan Way, Greenville, SC 29615-3514 Ph: (864) 775-6685 | Kyler Meredith Evans, CCC-SLP 35 Brendan Way, Greenville, SC 29615-3514 Ph: (864) 775-6685 |
News Archive
Severe cases of COVID-19 can involve extensive inflammation in the body, and clinicians have wondered if this state is similar to what are called cytokine storm syndromes, in which the immune system produces too many inflammatory signals that can sometimes lead to organ failure and death.
Two types of human antibodies that target different parts of the Ebola virus synergize their antiviral effects by inhibiting different steps of infection, according to a study published August 23 in the open-access journal PLOS Pathogens by Philipp Ilinykh and colleagues from the University of Texas Medical Branch, Vanderbilt University, and Ragon Institute.
"Almost every nation, regardless of its wealth and resources, faces a continuing shortage of nurses and an acute lack of nursing faculty available to educate more nurses. This dearth of practicing nurses and nurse educators is particularly critical in countries like Haiti and other developing high-risk, low-resourced nations," Martha Hill, dean of Johns Hopkins School of Nursing, writes in a Baltimore Sun opinion piece encouraging the expansion of global nursing.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
› Verified 1 days ago
Kaitlyn Ashley Fencik, M.A. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Prado Way, Greenville, SC 29607 Phone: 732-608-4098 | |
Mrs. Mary Carolyn Gilkinson, MSR, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 N Academy St, Greenville, SC 29601 Phone: 864-331-1380 | |
Andrea L. Murdock, S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 N Academy St, Greenville, SC 29601 Phone: 864-331-1350 | |
Olivia Catherine Bair, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Griffith Rd, Greenville, SC 29607 Phone: 864-990-1918 | |
Kaley Sanford Jennings, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Augusta St, Greenville, SC 29605 Phone: 864-370-0131 | |
Rachel Walker, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Pelham Ridge Dr, Greenville, SC 29615 Phone: 864-627-5097 Fax: 864-627-5099 |